Expert Interviews

Vaccination Strategies Practice Pearls And Key Take Aways
October 24, 2023

Drs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.

Case 3: 65-Year-Old Male Patient With An Egg Allergy
October 24, 2023

Drs Jacinda Abdul-Mutakabbir and Charles Vega share their expertise on how to vaccinate a 65-year-old male patient with an egg allergy.

Case 2: 29-Year-Old Female
October 24, 2023

Dr Arun B. Jesudian presents the case of a 29-Year-Old Female ultimately diagnosed with hepatic encephalopathy and discussed how he approached her treatment plan.

Case 1: 64-Year-Old Male
October 24, 2023

An expert in the management of liver conditions presents the case of a 64-Year-Old Male who presents to his PCP with abdominal distension, prompting clinical investigations resulting in a diagnosis of hepatic encephalopathy the currently available vaccine technologies, highlighting their mechanisms of action and individual delivery methods.

Treatment Considerations for Patients with Decompensated Cirrhosis and Hepatic Encephalopathy
October 24, 2023

Arun B. Jesudian, MD provides a didactic overview of cirrhosis, including its epidemiology and reviews the distinction between compensated and decompensated forms, focusing on hepatic encephalopathy as a complication of this condition.

Landscape of Multi-Cancer Early Detection Tests
October 20, 2023

Experts discuss the evolving landscape of multicancer early detection tests, including those in development and currently available.

Multi-Cancer Detection: Transforming Screening
October 20, 2023

Experts discuss the emerging landscape of multicancer early detection testing through liquid biopsy, highlighting its potential to revolutionize cancer screening.

Obesity and Hypertension: It’s a Complicated Relationship, Says One Clinician
October 19, 2023

President of the Alabama Obesity Society, Dr Jonathan Parker, provides an in-depth overview of the association between obesity and hypertension.

Potential Adverse Effects of Zuranolone in MDD
October 19, 2023

Experts in psychiatry review adverse effects of zuranolone, a γ-aminobutyric acid (GABA) receptor modulator, in the treatment of MDD.

GABAergic Modulating Treatment Considerations in MDD
October 19, 2023

Roger S. McIntyre, MD, FRCPC, comments on the paradigm shift of the frequency of dosing in the treatment of MDD, highlighting GABAergic modulating treatments, as well as the use of therapy to improve mental health.